According to FutureWise analysis, the market for African Horse Sickness Treatment is estimated to be US$ 0.84 billion in 2023 and is expected to reach US$ 2.98 billion by 2031 at a CAGR of 17.20% over the forecast period of 2025-2033.

African horse sickness (AHS) is a serious viral disease that affects equines and can be fatal in many cases. It is caused by the African horse sickness virus, which consists of nine distinct serotypes. The disease is highly contagious and poses significant health risks to horse populations. Although AHS primarily targets horses, it can also affect mules, donkeys, and zebras. Although other species such as elephants, camels, and dogs can contract the virus, they typically do not exhibit symptoms, often becoming infected through the consumption of contaminated horse meat. The disease is spread not directly between animals, but through insect vectors, with Culicoides midges being the primary carriers. Other vectors include various mosquitoes (such as Culex, Anopheles, and Aedes species, including A. aegypti) and certain tick species, such as Hyalomma and Rhipicephalus.

AHS manifests in several clinical forms. The peracute form is characterized by high fever and severe respiratory distress, often leading to death within 24 hours. The subacute cardiac form presents with fever, conjunctivitis, abdominal pain, and edema, resulting in a mortality rate of 50-70%. A mild variant of the condition is frequently observed in zebras and African donkeys, characterized by a low-grade fever and congested mucous membranes. Additionally, there exists a mixed form that encompasses features of both pulmonary and cardiac types, which is often fatal.

Diagnosing AHS involves monitoring clinical symptoms, performing post-mortem examinations, and detecting the presence of vector insects.. Laboratory confirmation can be achieved through viral isolation, quantitative PCR, antigen capture, and immunofluorescence techniques. Currently, there is no specific treatment available for AHS. Managing outbreaks requires a multifaceted approach, including quarantine measures, vector control efforts, and vaccination. Various vaccine types are utilized, including polyvalent, monovalent, and monovalent inactivated vaccines. Effective control of AHS also involves eliminating vector habitats and the application of insecticides to reduce transmission risk.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=13510&type=requestsample

 African Horse Sickness Treatment Market Segmentation:

• Prevention Treatment
• Vaccines

By Clinical Forms of The Disease

• Pulmonary Form or “Dunkop”
• Cardiac Form or “Dikkop”
• Mixed Form
• Horse Sickness Fever

By Diagnosis of the Disease And Prevention Strategies

• Diagnosis Tests
  • Laboratory Tests for Viral Antigens
  • Enzyme-linked Immunosorbent Assays (ELISA)
  • Reverse-transcription PCR Assays
• Serological Tests
• Prevention Treatment
• Vaccines

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

 Competitive Landscape in African Horse Sickness Treatment Market:

• Onderstepoort Biological Products SOC Ltd.
• Boehringer Ingelheim
• Zoetis
• Merial
• Veterinary Serum & Vaccine Research Institute

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=13510&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the African Horse Sickness Treatment Market By Clinical Forms of The Disease, By Diagnosis of the Disease And Prevention Strategies and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

            Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com